N
BOLD

Nuveen’s Audentes Therapeutics, Inc BOLD Stock Holding History

Nuveen’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-266,586
Closed -$16M – 3316
2019
Q4 		$16M Sell
266,586
-149,316
-36% -$5.6M 0.01% 1303
2019
Q3 		$11.7M Buy
415,902
+187,343
+82% +$6.39M ﹤0.01% 1468
2019
Q2 		$8.65M Buy
+228,559
New +$8.78M ﹤0.01% 1692

Nuveen's BOLD Position: Q1 2020 in Review

Nuveen sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 266,586 shares — an estimated $16M sold.

Nuveen first reported a position in BOLD in Q2 2019 and held it in 3 quarters. The position peaked at $16M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Nuveen reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Nuveen sold 266,586 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $16M.
  • Nuveen first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 3 quarters.
  • Nuveen's Audentes Therapeutics, Inc position peaked at $16M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Nuveen's 13F filing for Q1 2020, filed 14 May 2020.